Commercialisation & Outcomes Briefing

To develop and execute successful real world evidence, commercialisation and market access strategies for your product pipeline and on-market products, you need to stay fully informed about ongoing developments in global healthcare systems, relevant pricing and reimbursement trends and policies.

Download our latest issue to explore insights, information, and analysis on:

• Payer trends, and drivers of market access success

• Pricing policy and regulations in key markets

• Regulatory agency requirements and policies that govern market approval, and the impact on reimbursement decisions

• Innovative therapeutic advancements

Today, in an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, there has been growing interest among US politicians and the public in significant changes to the country’s healthcare system.

In this issue of ICON's briefing, our Pricing & Market Access team considers some of the leading proposals to expand healthcare and offers insights on the possible implications for US market access. We also provide an update from recent AMCP, IMPACT, and MAPS annual conferences to cover important trends and topics in the area of market access, commercialization, and communications.